SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193805-06-001296
Filing Date
2006-05-25
Accepted
2006-05-25 16:33:29
Documents
1
Group Members
DEERFIELD CAPITAL, L.P.DEERFIELD INTERNATIONAL LIMITEDDEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITEDDEERFIELD SPECIAL SITUATIONS FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 e600653_sc13g-parpharma.txt SC 13G 32750
  Complete submission text file 0001193805-06-001296.txt   35016
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 845-425-7100
PAR PHARMACEUTICAL COMPANIES, INC. (Subject) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-46121 | Film No.: 06867475
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address 212-551-1600
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G